<DOC>
	<DOCNO>NCT02137239</DOCNO>
	<brief_summary>Patients undergo kidney transplant require prolong therapy drug suppress immune system ( call immunosuppressive regimen ) stop immune system attack transplant kidney order limit damage possibility reject transplant kidney . The purpose study evaluate benefit risk two immunosuppressive regimen ( belatacept everolimus tacrolimus mycophenolate mofetil ) follow thymoglobulin induction rapid corticosteroid withdrawal .</brief_summary>
	<brief_title>Regimen Optimization Study</brief_title>
	<detailed_description>Calcineurin inhibitor ( CNI )</detailed_description>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Men woman , age 18 75 Serologic test result positive past exposure Epstein Barr Virus ( EBV+ ) Diagnosed end stage renal disease ( ESRD ) schedule undergo transplantation nonHLA identical , live standard criterion decease donor kidney Primary cause ESRD : primary focal segmental glomerulosclerosis ; Type I II membranoproliferative glomerulonephritis ; Hemolytic Uremic Syndrome / Thrombotic Thrombocytopenic Purpura Had previous graft loss due acute rejection At increase immunologic risk graft loss due panel reactive antibody ( PRA ) &gt; 20 % need desensitization therapy Scheduled receive : kidney identical twin ; pair kidney ; kidney Cytomegalovirus ( CMV ) positive donor recipient CMV negative ; kidney extend criterion donor Have body mass index ( BMI ) &gt; 35 kg/m2 nondiabetics &gt; 30 kg/m2 diabetic Diagnosed Hepatitis B positive ; Hepatitis C positive ; HIV positive ; currently previously active inadequately treated latent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>